David Cunningham
机构: The Royal Marsden NHS Foundation Trust
每年引用次数
引用次数
引用: 138,998
H-指数: 159
I10-指数 : 859
出版物: 1,971
Adjuvant chemotherapy versus observation in patients with colorectal cancer : a randomised study. Commentary
Naureen Starling , David Cunningham
The Lancet 370 ( 9604)
2007
Therapeutic options in gastric cancer: neoadjuvant chemotherapy vs postoperative chemoradiotherapy.
David Cunningham , Christopher Jackson , Kazimierz Mochlinski
Oncology 21 ( 9) 1084 -1087
6
2007
Prognostic value of pretreatment 18F-FDG-PET/CT in colorectal liver metastasis
Ian Chau , David Cunningham , Gary Cook , Dow-Mu Koh
Society of Nuclear Medicine Annual Meeting Abstracts 51 283
2010
Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma
Catherine Thieblemont , Umberto Vitolo , Franck Morschhauser , Kim Linton
In: EORTC-NCI-AACR meeting; Barcelona, Spain. 2014.
2014
Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed.
Peter V. Danenberg , Jan Brabender , Ann L. Jackman , G. Wynne Aherne
Clinical Cancer Research 9 ( 2) 792 -801
61
2003
Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study
Jennifer Gansert , Mario E. Barugel , James Cassidy , David Cunningham
Onkologie : international journal for cancer research and treatment 33 68 -69
2010
Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling.
R Ian Swift , David Cunningham , Paul A Clarke , Mark E Hill
Cancer Research 63 ( 20) 6855 -6863
33
2003
Prime study : a randomised phase 3 study of panitumumab with Folfox4 versus Folfox4 alone as first line treatment for metastatic colorectal cancer (mCRC)
Jennifer Gansert , Mario E. Barugel , James Cassidy , David Cunningham
Annals of Oncology 21
1
2010
Targeting angiogenesis in advanced gastric cancer: Is this end of the road?
Vikram K Jain , David Cunningham
Translational gastrointestinal cancer 1 ( 1) 119 -121
2
2012
Neoadjuvant chemotherapy for gastric cancer
Ian Chau , Kate Young , David Cunningham , Anna Minchom
Translational gastrointestinal cancer 1 ( 3) 202 -204
4
2012
Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.
A. Hilary Calvert , Ann L. Jackman , Fraser Mitchell , David Cunningham
Clinical Cancer Research 8 ( 1) 103 -109
30
2002
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil.
Lorena Bottarelli , Alessandra Mandolesi , Nicoletta Campanini , Francesca V. Negri
Anticancer Research 33 ( 10) 4611 -4617
7
2013
OUP: The Development of an Australian List 1975-85
David Cunningham
Publishing Studies ( 3) 7
1
1996
The potential added value of F-18 fluoroethylcholine PET-CT(FCH) in assessment of viable disease in treated primary cerebral lymphoma (PCL)
Ian Chau , David Cunningham , Bhupinder Sharma , YiLiang Thian
The Journal of Nuclear Medicine 55 527 -527
2014
Combination chemotherapy and colorectal cancer.
David Cunningham , Kate Sumpter
Seminars in Oncology 27 ( 5) 105 -111
3
2000
Accomplishments in 2008 in the management of localized gastric cancer.
Yung-Jue Bang , Alicia Okines , David Cunningham
Gastrointestinal Cancer Research : GCR 3
1
2009
New directions in the systemic treatment of GI cancer
Nuri Aykan , David Cunningham , Dirk Arnold , Andrés Cervantes
Annals of Oncology 17
2006
Phase 2a study of copanlisib, a novel phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with relapsed/refractory, idolent or aggressive lymphoma
Kim Linton , Marius Giurescu , Julia Grunert , David Cunningham
British Society for Haematology 55th Annual Scientific Meeting
2015
Outcomes of Peripheral T-cell Lymphoma in the Current Era: 10 Year Experience at The Royal Marsden and Christie Hospitals.
Mark Ethell , Ian Chau , Kim Linton , Andrew Wotherspoon
57th American Society of Hematology Annual Meeting and Exposition
2015
A Low-Cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-Relevant Subtypes
Anguraj Sadanandam , Anguraj Sadanandam , Pawan Poudel , Pierre Martineau
bioRxiv 174847
6
2017